Skip to main contentSkip to breadcrumbsSkip to sub navSkip to doormat

Barry Dickson appointed new Director of the IMP


15 Feb 2005

The Australian neurobiologist Barry Dickson is to head the Research Institute of Molecular Pathology (IMP) in Vienna, a subsidiary of the Boehringer Ingelheim Group. He will succeed the British geneticist Kim Nasmyth who has accepted a call to Oxford University from the beginning of 2006.


Related Documents